Product Program year 2024 Source: CMS Open Payments

Optisure

Device Cardiac Rhythm Management

PDI 05414734507486

Open in the dashboard

General payments

$29,175

352 payments

Research payments

$101,514

10 payments

Through program year 2024, $29,175 in general payments and $101,514 in research payments were reported against Optisure (Cardiac Rhythm Management).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2024 General $1,268 39
2023 General $1,802 74
2023 Research $46,702 3
2022 General $26,105 239
2022 Research $54,811 7

Breakdown

Who paid General payments · program years 2022–2024
  1. Abbott Laboratories $29,175 352 payments
Top recipients General payments · program year 2024
  1. David Boone Ophthalmology · Macon, GA $126 10% · 2 payments
  2. Khashayar Hematpour Cardiovascular Disease · Boston, MA $102 8% · 3 payments
  3. Vivek Menon Clinical Cardiac Electrophysiology · Lufkin, TX $102 8% · 2 payments
  4. Scott Schubert Clinical Cardiac Electrophysiology · Grapevine, TX $82 6% · 2 payments
  5. Chandra Hendrix Nurse Practitioner, Family · Humble, TX $77 6% · 1 payment

The top 5 of 31 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Clinical Cardiac Electrophysiology Internal Medicine $417 34% · 13 practitioners
  2. Cardiovascular Disease Internal Medicine $221 18% · 5 practitioners
  3. Ophthalmology $126 10% · 1 practitioner
  4. Nurse Practitioner, Acute Care Nurse Practitioner $105 9% · 2 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $102 8% · 2 practitioners

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Texas $591 47% · 11 recipients
  2. Georgia $126 10% · 1 recipient
  3. Massachusetts $102 8% · 1 recipient
  4. Ohio $102 8% · 1 recipient
  5. Arizona $75 6% · 4 recipients

The top 5 of 11 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

352 general · 10 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record